Pluristem reports topline results from Covid-19 therapy trial
Pluristem Therapeutics has reported topline results from its Phase II studies of PLX-PAD cells to treat acute respiratory distress syndrome…
All articles by
-
-
FDA approves IND application of Accutar for prostate cancer treatment trial
The US Food and Drug Administration (FDA) has approved Accutar Biotechnology’s Investigational New Drug (IND) application for Phase I clinical…
-
Ventura County Hematology Oncology to use Deep Lens’ clinical trial solution
Ventura County Hematology Oncology Specialists has signed an agreement to integrate Deep Lens’ clinical trial matching solution which is based…
-
Immunic enrols first subject in prostate cancer therapy trial
Immunic has enrolled the first subject in its Phase I clinical trial of IMU-935 to treat metastatic castration-resistant prostate cancer…